Back to New York

S10480 • 2025

Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing

Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Jessica Scarcella-Spanton
Last action
2026-05-15
Official status
In Senate Committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing

Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing upon the recommendation of a health care provider; makes related provisions.

What This Bill Does

  • Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing upon the recommendation of a health care provider; makes related provisions.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-05-15 Senate

    REFERRED TO INSURANCE

Official Summary Text

Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing
Provides for mandatory health insurance coverage for coronary artery calcium diagnostic testing upon the recommendation of a health care provider; makes related provisions.

Current Bill Text

Read the full stored bill text
S T A T E   O F   N E W   Y O R K
        ________________________________________________________________________

                                          10480

                                    I N  S E N A T E

                                      May 15, 2026
                                       ___________

        Introduced  by Sen. SCARCELLA-SPANTON -- read twice and ordered printed,
          and when printed to be committed to the Committee on Insurance

        AN ACT to amend the insurance  law,  in  relation  to  mandatory  health
          insurance coverage for coronary artery calcium diagnostic testing

          THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
        BLY, DO ENACT AS FOLLOWS:

     1    Section 1. Subsection (i) of section 3216  of  the  insurance  law  is
     2  amended by adding a new paragraph 42 to read as follows:
     3    (42)  (A) EVERY POLICY WHICH PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMI-
     4  LAR COMPREHENSIVE-TYPE COVERAGE  SHALL  PROVIDE  COVERAGE  FOR  CORONARY
     5  ARTERY  CALCIUM  DIAGNOSTIC  TESTING UPON THE RECOMMENDATION OF A HEALTH
     6  CARE PROVIDER ACTING WITHIN SUCH PROVIDER'S SCOPE OF  PRACTICE  PURSUANT
     7  TO  TITLE  EIGHT  OF THE EDUCATION LAW, AND AS RECOMMENDED BY NATIONALLY
     8  RECOGNIZED CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION OF CARDIOVAS-
     9  CULAR DISEASE.
    10    (B) NOTWITHSTANDING ANY  OTHER  PROVISION  OF  LAW,  ANY  POLICY  THAT
    11  PROVIDES  COVERAGE  REQUIRED  BY THIS PARAGRAPH SHALL NOT IMPOSE PATIENT
    12  COST SHARING FOR CORONARY ARTERY CALCIUM DIAGNOSTIC TESTING.
    13    (C) FOR THE PURPOSES OF THIS PARAGRAPH, THE  TERM  "NATIONALLY  RECOG-
    14  NIZED  CLINICAL  PRACTICE  GUIDELINES"  SHALL  MEAN EVIDENCE-BASED, PEER
    15  REVIEWED CLINICAL PRACTICE GUIDELINES INFORMED BY A SYSTEMATIC REVIEW OF
    16  EVIDENCE AND AN ASSESSMENT OF THE BENEFITS,  AND  RISKS  OF  ALTERNATIVE
    17  CARE  OPTIONS INTENDED TO OPTIMIZE PATIENT CARE DEVELOPED BY INDEPENDENT
    18  ORGANIZATIONS OR MEDICAL PROFESSIONAL SOCIETIES UTILIZING A  TRANSPARENT
    19  METHODOLOGY  AND  REPORTING  STRUCTURE  AND  WITH A CONFLICT OF INTEREST
    20  POLICY.
    21    (D) NOTHING IN THIS PARAGRAPH SHALL BE CONSTRUED  TO  PREVENT  MEDICAL
    22  MANAGEMENT  OR UTILIZATION REVIEW OF THE SERVICES, INCLUDING PREAUTHORI-
    23  ZATION, TO ENSURE THAT SUCH  SERVICES  ARE  CONSISTENT  WITH  NATIONALLY
    24  RECOGNIZED CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION OF CARDIOVAS-
    25  CULAR DISEASE.
    26    (E)  IF  THE  POLICY  IS  A  HIGH DEDUCTIBLE HEALTH PLAN AS DEFINED IN
    27  SECTION 223(C)(2) OF THE INTERNAL REVENUE CODE OF  1986,  SUCH  COVERAGE

         EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD15931-01-6
        S. 10480                            2

     1  MAY  BE  SUBJECT  TO THE PLAN'S ANNUAL DEDUCTIBLE IF APPLICATION OF THIS
     2  REQUIREMENT WOULD RESULT IN INELIGIBILITY FOR A HEALTH SAVINGS ACCOUNT.
     3    § 2. Subsection (l) of section 3221 of the insurance law is amended by
     4  adding a new paragraph 24 to read as follows:
     5    (24)  (A) EVERY POLICY WHICH PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMI-
     6  LAR COMPREHENSIVE-TYPE COVERAGE  SHALL  PROVIDE  COVERAGE  FOR  CORONARY
     7  ARTERY  CALCIUM  DIAGNOSTIC  TESTING UPON THE RECOMMENDATION OF A HEALTH
     8  CARE PROVIDER ACTING WITHIN SUCH PROVIDER'S SCOPE OF  PRACTICE  PURSUANT
     9  TO  TITLE  EIGHT  OF THE EDUCATION LAW, AND AS RECOMMENDED BY NATIONALLY
    10  RECOGNIZED CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION OF CARDIOVAS-
    11  CULAR DISEASE.
    12    (B) NOTWITHSTANDING ANY  OTHER  PROVISION  OF  LAW,  ANY  POLICY  THAT
    13  PROVIDES  COVERAGE  REQUIRED  BY THIS PARAGRAPH SHALL NOT IMPOSE PATIENT
    14  COST SHARING FOR CORONARY ARTERY CALCIUM DIAGNOSTIC TESTING.
    15    (C) FOR THE PURPOSES OF THIS PARAGRAPH, THE  TERM  "NATIONALLY  RECOG-
    16  NIZED  CLINICAL  PRACTICE  GUIDELINES"  SHALL  MEAN EVIDENCE-BASED, PEER
    17  REVIEWED CLINICAL PRACTICE GUIDELINES INFORMED BY A SYSTEMATIC REVIEW OF
    18  EVIDENCE AND AN ASSESSMENT OF THE BENEFITS,  AND  RISKS  OF  ALTERNATIVE
    19  CARE  OPTIONS INTENDED TO OPTIMIZE PATIENT CARE DEVELOPED BY INDEPENDENT
    20  ORGANIZATIONS OR MEDICAL PROFESSIONAL SOCIETIES UTILIZING A  TRANSPARENT
    21  METHODOLOGY  AND  REPORTING  STRUCTURE  AND  WITH A CONFLICT OF INTEREST
    22  POLICY.
    23    (D) NOTHING IN THIS PARAGRAPH SHALL BE CONSTRUED  TO  PREVENT  MEDICAL
    24  MANAGEMENT  OR UTILIZATION REVIEW OF THE SERVICES, INCLUDING PREAUTHORI-
    25  ZATION, TO ENSURE THAT SUCH  SERVICES  ARE  CONSISTENT  WITH  NATIONALLY
    26  RECOGNIZED CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION OF CARDIOVAS-
    27  CULAR DISEASE.
    28    (E)  IF  THE  POLICY  IS  A  HIGH DEDUCTIBLE HEALTH PLAN AS DEFINED IN
    29  SECTION 223(C)(2) OF THE INTERNAL REVENUE CODE OF  1986,  SUCH  COVERAGE
    30  MAY  BE  SUBJECT  TO THE PLAN'S ANNUAL DEDUCTIBLE IF APPLICATION OF THIS
    31  REQUIREMENT WOULD RESULT IN INELIGIBILITY FOR A HEALTH SAVINGS ACCOUNT.
    32    § 3. Section 4303 of the insurance law is  amended  by  adding  a  new
    33  subsection (yy) to read as follows:
    34    (YY)  (1)  EVERY  CONTRACT  WHICH  PROVIDES MEDICAL, MAJOR MEDICAL, OR
    35  SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE FOR  CORONARY
    36  ARTERY  CALCIUM  DIAGNOSTIC  TESTING UPON THE RECOMMENDATION OF A HEALTH
    37  CARE PROVIDER ACTING WITHIN SUCH PROVIDER'S SCOPE OF  PRACTICE  PURSUANT
    38  TO  TITLE  EIGHT  OF THE EDUCATION LAW, AND AS RECOMMENDED BY NATIONALLY
    39  RECOGNIZED CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION OF CARDIOVAS-
    40  CULAR DISEASE.
    41    (2) NOTWITHSTANDING ANY OTHER PROVISION  OF  LAW,  ANY  CONTRACT  THAT
    42  PROVIDES  COVERAGE  REQUIRED BY THIS SUBSECTION SHALL NOT IMPOSE PATIENT
    43  COST SHARING FOR CORONARY ARTERY CALCIUM DIAGNOSTIC TESTING.
    44    (3) FOR THE PURPOSES OF THIS SUBSECTION, THE TERM  "NATIONALLY  RECOG-
    45  NIZED  CLINICAL  PRACTICE  GUIDELINES"  SHALL  MEAN EVIDENCE-BASED, PEER
    46  REVIEWED CLINICAL PRACTICE GUIDELINES INFORMED BY A SYSTEMATIC REVIEW OF
    47  EVIDENCE AND AN ASSESSMENT OF THE BENEFITS,  AND  RISKS  OF  ALTERNATIVE
    48  CARE  OPTIONS INTENDED TO OPTIMIZE PATIENT CARE DEVELOPED BY INDEPENDENT
    49  ORGANIZATIONS OR MEDICAL PROFESSIONAL SOCIETIES UTILIZING A  TRANSPARENT
    50  METHODOLOGY  AND  REPORTING  STRUCTURE  AND  WITH A CONFLICT OF INTEREST
    51  POLICY.
    52    (4) NOTHING IN THIS SUBSECTION SHALL BE CONSTRUED TO  PREVENT  MEDICAL
    53  MANAGEMENT  OR UTILIZATION REVIEW OF THE SERVICES, INCLUDING PREAUTHORI-
    54  ZATION, TO ENSURE THAT SUCH  SERVICES  ARE  CONSISTENT  WITH  NATIONALLY
    55  RECOGNIZED CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION OF CARDIOVAS-
    56  CULAR DISEASE.
        S. 10480                            3

     1    (5)  IF  THE  CONTRACT  IS A HIGH DEDUCTIBLE HEALTH PLAN AS DEFINED IN
     2  SECTION 223(C)(2) OF THE INTERNAL REVENUE CODE OF  1986,  SUCH  COVERAGE
     3  MAY  BE  SUBJECT  TO THE PLAN'S ANNUAL DEDUCTIBLE IF APPLICATION OF THIS
     4  REQUIREMENT WOULD RESULT IN INELIGIBILITY FOR A HEALTH SAVINGS ACCOUNT.
     5    § 4. This act shall take effect January 1, 2027 and shall apply to all
     6  policies  and contracts issued, renewed, modified, altered or amended on
     7  or after such date.